Seeking Alpha

Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary ETESIAN Asthma Data Transcript

Thank you for standing by. Welcome to the Jasper Therapeutics Data Update Webinar. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Jasper ...
KTBS 3

Senate investigation: drugmaker harmed patients, profited, with asthma inhaler switch

In 2024, doctors and parents scrambled to find an affordable asthma inhaler after drugmaker GSK pulled the popular Flovent ...
Seeking Alpha

Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation

REDWOOD CITY, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody ...